Uwe Platzbecker

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Uwe Platzbecker
Feb 25, 2025, 08:29 | Science
Maximilian Merz: What is the biology behind CAR+ T-cell lymphomas?
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared an…
Dec 12, 2024, 13:36 | Insight
Nico Gagelmann: Tandem transplant for myeloma patients with sub-optimal responses to induction therapy
Nico Gagelmann, Co-founder and Co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Nov 14, 2024, 14:05 | Insight
Myeloma Paper of the Day, November 14th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Allogeneic transplant for therapy-related myeloid…
Oct 31, 2024, 06:01 | Insight
Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma
Nico Gagelmann, Co- Chair of the The EBMT Trainee Committee, shared on X: “Finally out!…
Oct 24, 2024, 15:45 | Blog
Myeloma Paper of the Day, October 24th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Paper of the Day: Bispecific antibodies as bridging to BCMA…
Sep 4, 2024, 17:52 | Blog
Ryan Fitzpatrick: The 6th annual MPN MDS EU Focus meeting by MD Education
Ryan Fitzpatrick, CEO and Founder, MD Education, shared a post on LinkedIn: "A great 2 day…
Jul 21, 2024, 20:39 | Blog
Matteo Della Porta: The final analysis of the COMMANDS trial comparing Luspatercept vs Epoetin alfa
Matteo Della Porta, Professor of Hematology at Humanitas University and Head of CALR (Center for…
May 29, 2024, 14:57 | Blog
Anne Sophie Kubasch: The preliminary program for our upcoming event ‘Shaping the Future of Medicine 2024'
Anne Sophie Kubasch, Specialist Physician for Internal Medicine, Hematology and Oncology at University Leipzig, shared a…
Apr 24, 2024, 18:36 | Blog
Maximilian Merz: Smells like team spirit
Maximilian Merz, Head of Early Clinical Trials at the Leipzig University, shared a post on…
Jan 16, 2024, 16:56 | Blog
ALLG, in 2024, continues its five decades of impact - Australasian Leukaemia and Lymphoma Group
Australasian Leukaemia & Lymphoma Group shared a post on LinkedIn. "ALLG, in 2024, continues its…
Oct 25, 2023, 18:33 | Blog
Uwe Platzbecker: He is a role model for how important patient participation and clinical trials are
Quoting Uwe Platzbecker, Head of Medical Department 1, Hematology and Cellular Therapy at Leipzig University,…
Jul 9, 2023, 09:28 | Insight
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms - Uwe Platzbecker
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms. Specific subsets of LR-MDS…
All: 12 Posts: 1 - 100
Special Coverage